A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy

NCT02776527 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Apatinib Mesylate Tablets

Sponsor

Tianjin Medical University Cancer Institute and Hospital